# Tobira Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tobira-therapeutics

- Industry: Pharmaceuticals
- Headquarters: South San Francisco, US
- Website: www.tobiratherapeutics.com
- Total disclosed funding: $62M
- Latest round: Series B (Sep 29, 2010)
- Investors on record: 5

## About

Established in 2006, Tobira Therapeutics is a biopharmaceutical company based in California, US. The firm engages in the development and commercialization of antiviral compounds for HIV treatment.

## Funding rounds

- Series B, Sep 29, 2010, $31M — Domain Associates, Frazier Healthcare Partners, Canaan Partners, Montreux Equity Partners, Novo Holdings
- Series A, Aug 1, 2007, $31M — Domain Associates, Frazier Healthcare Partners, Canaan Partners, Montreux Equity Partners

## Investors

- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series A, Series B
- Frazier Healthcare Partners (https://capitalatlas.ai/funds/frazier-healthcare-partners) — Series A, Series B
- Canaan Partners (https://capitalatlas.ai/funds/canaan-partners) — Series A, Series B
- Montreux Equity Partners (https://capitalatlas.ai/funds/montreux-equity-partners) — Series A, Series B
- Novo Holdings — Series B
